These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 22406584)
1. Intraductal papillary mucinous neoplasms of the pancreas: clinical surveillance and malignant progression, multifocality and implications of a field-defect. Remotti HE; Winner M; Saif MW JOP; 2012 Mar; 13(2):135-8. PubMed ID: 22406584 [TBL] [Abstract][Full Text] [Related]
2. Intraductal papillary mucinous neoplasms of the pancreas (IPMNs): epidemiology, diagnosis and future aspects. Konstantinou F; Syrigos KN; Saif MW JOP; 2013 Mar; 14(2):141-4. PubMed ID: 23474557 [TBL] [Abstract][Full Text] [Related]
3. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488 [TBL] [Abstract][Full Text] [Related]
4. [Pancreatic ductal carcinoma concomitant with intraductal papillaly mucinous neoplasm]. Suzuki Y; Sugiyama M; Nakazato T; Yokoyama M; Abe N; Masaki T; Mori T; Hara Y; Ohkura Y Gan To Kagaku Ryoho; 2012 Mar; 39(3):347-50. PubMed ID: 22421759 [TBL] [Abstract][Full Text] [Related]
6. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145 [TBL] [Abstract][Full Text] [Related]
7. Intraductal papillary mucinous neoplasia (IPMN). Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010. Bussom S; Saif MW JOP; 2010 Mar; 11(2):131-4. PubMed ID: 20208320 [TBL] [Abstract][Full Text] [Related]
8. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Tanno S; Nakano Y; Sugiyama Y; Nakamura K; Sasajima J; Koizumi K; Yamazaki M; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y Pancreatology; 2010; 10(2-3):173-8. PubMed ID: 20484955 [TBL] [Abstract][Full Text] [Related]
9. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241 [TBL] [Abstract][Full Text] [Related]
10. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671 [TBL] [Abstract][Full Text] [Related]
11. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512 [TBL] [Abstract][Full Text] [Related]
19. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma. Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma. Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]